Jared W Magnani1, Danielle Ferry2, Gretchen Swabe2, Deborah Martin3, Xirun Chen3, Maria M Brooks3, Everlyne Kimani4, Michael K Paasche-Orlow5, Stefán Ólafsson6, Timothy Bickmore4, Samar R El Khoudary3. 1. Department of Medicine, University of Pittsburgh, Pittsburgh, PA; Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA. Electronic address: magnanijw@upmc.edu. 2. Department of Medicine, University of Pittsburgh, Pittsburgh, PA. 3. Department of Epidemiology, University of Pittsburgh Graduate School of Public Health, Pittsburgh, PA. 4. Human Computer Interaction Institute, Northeastern University, Boston, MA. 5. Department of General Internal Medicine, Boston University School of Medicine, Boston, MA. 6. Human Computer Interaction Institute, Northeastern University, Boston, MA; Department of Computer Science, Reykjavik University, Iceland.
Abstract
BACKGROUND: Atrial fibrillation (AF) is a highly morbid condition which requires long-term adherence to oral anticoagulation and may be associated with adverse quality of life and health care utilization. We developed a relational agent-an interactive smartphone-based intervention accessible regardless of digital or health literacy-to assist individuals residing in rural, Western Pennsylvania, with AF with chronic disease self-management. METHODS: The "Mobile health intervention for rural atrial fibrillation" is a single center, parallel-arm randomized clinical trial for adults with AF funded by the National Institute of Health's National Heart, Lung, and Blood Institute to enroll 264 participants. All participants receive a smartphone with data plan: The intervention is a 4 month relational agent coupled with the AliveCor Kardia for heart rate and rhythm monitoring provided by smartphone, and the control a pre-installed, smartphone-based application for health-related information (WebMD). The study uses remote recruitment and engagement to enroll individuals who would otherwise be unlikely to participate in clinical research due to rurality. The primary outcome of the trial is adherence to oral anticoagulation, determined by proportion of days covered, as measured at 12 months. The secondary outcomes are quality of life, both AF-specific and general, and health care utilization. The study entails a baseline visit, a 4 month intervention phase, and 8 and 12 month follow-up visits. CONCLUSIONS: This mobile health trial tests the effectiveness of a smartphone-based relational agent to improve clinical and patient-reported outcomes in rural-dwelling individuals.
BACKGROUND: Atrial fibrillation (AF) is a highly morbid condition which requires long-term adherence to oral anticoagulation and may be associated with adverse quality of life and health care utilization. We developed a relational agent-an interactive smartphone-based intervention accessible regardless of digital or health literacy-to assist individuals residing in rural, Western Pennsylvania, with AF with chronic disease self-management. METHODS: The "Mobile health intervention for rural atrial fibrillation" is a single center, parallel-arm randomized clinical trial for adults with AF funded by the National Institute of Health's National Heart, Lung, and Blood Institute to enroll 264 participants. All participants receive a smartphone with data plan: The intervention is a 4 month relational agent coupled with the AliveCor Kardia for heart rate and rhythm monitoring provided by smartphone, and the control a pre-installed, smartphone-based application for health-related information (WebMD). The study uses remote recruitment and engagement to enroll individuals who would otherwise be unlikely to participate in clinical research due to rurality. The primary outcome of the trial is adherence to oral anticoagulation, determined by proportion of days covered, as measured at 12 months. The secondary outcomes are quality of life, both AF-specific and general, and health care utilization. The study entails a baseline visit, a 4 month intervention phase, and 8 and 12 month follow-up visits. CONCLUSIONS: This mobile health trial tests the effectiveness of a smartphone-based relational agent to improve clinical and patient-reported outcomes in rural-dwelling individuals.
Authors: Barry D Weiss; Mary Z Mays; William Martz; Kelley Merriam Castro; Darren A DeWalt; Michael P Pignone; Joy Mockbee; Frank A Hale Journal: Ann Fam Med Date: 2005 Nov-Dec Impact factor: 5.166
Authors: Paul A Harris; Robert Taylor; Brenda L Minor; Veida Elliott; Michelle Fernandez; Lindsay O'Neal; Laura McLeod; Giovanni Delacqua; Francesco Delacqua; Jacqueline Kirby; Stephany N Duda Journal: J Biomed Inform Date: 2019-05-09 Impact factor: 6.317
Authors: Margaret C Fang; Alan S Go; Yuchiao Chang; Leila H Borowsky; Niela K Pomernacki; Natalia Udaltsova; Daniel E Singer Journal: Circ Cardiovasc Qual Outcomes Date: 2010-10-19
Authors: Konstantinos N Aronis; Brittany Edgar; Wendy Lin; Maria Auxiliadora Parreiras Martins; Michael K Paasche-Orlow; Jared W Magnani Journal: Eur Cardiol Date: 2017
Authors: Kevin A Matthews; Janet B Croft; Yong Liu; Hua Lu; Dafna Kanny; Anne G Wheaton; Timothy J Cunningham; Laura Kettel Khan; Ralph S Caraballo; James B Holt; Paul I Eke; Wayne H Giles Journal: MMWR Surveill Summ Date: 2017-02-03
Authors: Jared W Magnani; Courtney L Schlusser; Everlyne Kimani; Bruce L Rollman; Michael K Paasche-Orlow; Timothy W Bickmore Journal: JMIR Cardio Date: 2017-12-12